BriaCell Therapeutics Corp. Warrant expiring 2031
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that… Read more
Market Cap & Net Worth: BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)
BriaCell Therapeutics Corp. Warrant expiring 2031 (NASDAQ:BCTXL) has a market capitalization of $11.84K ($11.84K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #34266 globally and #11165 in its home market, demonstrating a 21.21% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BriaCell Therapeutics Corp. Warrant expiring 2031's stock price $1.20 by its total outstanding shares 9870 (9.87K).
BriaCell Therapeutics Corp. Warrant expiring 2031 Market Cap History: 2026 to 2026
BriaCell Therapeutics Corp. Warrant expiring 2031's market capitalization history from 2026 to 2026. Data shows growth from $11.84K to $11.84K (0.00% CAGR).
BriaCell Therapeutics Corp. Warrant expiring 2031 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BriaCell Therapeutics Corp. Warrant expiring 2031's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BCTXL by Market Capitalization
Companies near BriaCell Therapeutics Corp. Warrant expiring 2031 in the global market cap rankings as of March 19, 2026.
Key companies related to BriaCell Therapeutics Corp. Warrant expiring 2031 by market ranking:
- Edison Lithium Corp (V:EDDY): Ranked #34257 globally with a market cap of $2.00 Million USD ( CA$2.88 Million CAD).
- SACCHERIA F.LLI FRANCES. (F:YV1): Ranked #34258 globally with a market cap of $2.00 Million USD ( €1.95 Million EUR).
- Rogue Resources Inc (PINK:GCRIF): Ranked #34267 globally with a market cap of $2.00 Million USD.
- Iconic Minerals Ltd. (OTCQB:ICMFF): Ranked #34268 globally with a market cap of $2.00 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #34257 | Edison Lithium Corp | V:EDDY | $2.00 Million | CA$0.10 |
| #34258 | SACCHERIA F.LLI FRANCES. | F:YV1 | $2.00 Million | €1.30 |
| #34267 | Rogue Resources Inc | PINK:GCRIF | $2.00 Million | $0.05 |
| #34268 | Iconic Minerals Ltd. | OTCQB:ICMFF | $2.00 Million | $0.01 |
BriaCell Therapeutics Corp. Warrant expiring 2031 Historical Marketcap From 2026 to 2026
Between 2026 and today, BriaCell Therapeutics Corp. Warrant expiring 2031's market cap moved from $11.84K to $ 11.84K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.84K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BriaCell Therapeutics Corp. Warrant expiring 2031 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.84K USD |
| MoneyControl | $11.84K USD |
| MarketWatch | $11.84K USD |
| marketcap.company | $11.84K USD |
| Reuters | $11.84K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.